Finance

Beta
Lists
KPRX:NASDAQ
Kiora Pharmaceuticals Inc
$2.63
-1.13%
(-0.030) 1D
Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KPRX...
Open
$2.68
High
$2.74
Low
$2.62
Mkt. cap
11.66M
Avg. vol.
28.68K
Volume
8.96K
52-wk high
$3.29
52-wk low
$1.76
EPS
-$2.68
Beta
-0.40
Shares outstanding
4.43M
No. of employees
13
Open
$2.68
High
$2.74
Low
$2.62
Mkt. cap
11.66M
Avg. vol.
28.68K
Volume
8.96K
52-wk high
$3.29
52-wk low
$1.76
EPS
-$2.68
Beta
-0.40
Shares outstanding
4.43M
No. of employees
13
News stories
From sources across the web
About Kiora Pharmaceuticals Inc
CEO-
Employees13
Founded1998
HeadquartersEncinitas, California, United States
SectorPharmaceutical industry
Analyst ratings
Based on 1 analyst giving stock ratings to KPRX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for KPRX in the last 3 months
Highest
Current $2.63
$12.00 (+356.27%)
Average
$12.00 (+356.27%)
Lowest
$12.00 (+356.27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Maintained
$12.00
+356.3%
06/22/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
904.57K
1.07M
1.17M
890.50K
Cost of revenue
904.57K
1.07M
1.17M
890.50K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.35M
1.44M
1.46M
1.61M
Operating expense
1.35M
1.44M
1.46M
1.61M
Total operating expenses
2.26M
2.52M
2.63M
2.50M
Operating income
-2.26M
-2.52M
-2.63M
-2.50M
Other non operating income
-93.56K
-23.71K
173.24K
-47.13K
EBT including unusual items
-2.26M
-616.32K
-7.17M
-2.42M
EBT excluding unusual items
-2.13M
-2.34M
-2.49M
-2.41M
Income tax expense
-112.06K
-643.13K
-649.97K
-
Effective tax rate
4.95%
104.35%
9.07%
-
Other operating expenses
-
-
-
-
Net income
-2.15M
26.81K
-6.52M
-2.42M
Net profit margin
-
-
-
-
Earnings per share
-0.54
0.01
-
-
Interest and investment income
225.24K
201.82K
190.31K
139.34K
Interest expense
-
-
-19.96K
-
Net interest expenses
225.24K
201.82K
170.35K
139.34K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.25M
-2.50M
-2.62M
-2.49M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more